Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study)

Table 1

Baseline demographic and disease characteristics.

Characteristics	Unilateral DME; ()	Bilateral DME ()
Age, mean ± SD, years	66.36 ± 9.1	64.69 ± 9.2
Male (%)	60.51	63.74
Caucasians (%)	100	99.34
Baseline BCVA, mean ± SD
Decimal score (value/10)	3.98 ± 2.24	3.56 ± 2.03
Snellen (20/value)	82.13 ± 84.71	91.95 ± 142.00
Age at first DME diagnosis,; mean ± SD, years	63.84 ± 9.34	61.65 ± 9.23
Time from DME diagnosis to study entry, mean ± SD, years	2.57 ± 3.35	3.26 ± 3.11

BCVA, best-corrected visual acuity; DME, diabetic macular edema; SD, standard deviation.